KIDRON NADAV 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
KIDRON NADAV
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-07-28+126,000→ 1,090,729 total - Award
Common Stock
2022-07-28+34,000→ 964,729 total - Tax Payment
Common Stock
2022-08-01$8.36/sh−12,631$105,595→ 1,078,098 total
Footnotes (3)
- [F1]Represents Common Stock granted by the Issuer that vested on August 1, 2022.
- [F2]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 42,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F3]Payment of tax liability by withholding securities related to the 34,000 shares of Common Stock granted on July 28, 2022.